Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Catheter-Directed Thrombolysis in Acute Iliofemoral Deep Vein Thrombosis with or without Stenting: A Case Series.

Haji Zeinali AM, Jenab Y, Ariannejad H, Kassaian SE, Alidoosti M, Aghajani H, Zafarghandi MR.

J Tehran Heart Cent. 2018 Oct;13(4):186-190.

2.

Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Protocol for a Cross-Sectional Study.

Nozari Y, Geraiely B, Alipasandi K, Jalali A, Omidi N, Aghajani H, Hajizeinali A, Alidoosti M, Pourhoseini H, Salarifar M, Amirzadegan A, Nematipour E, Nomali M.

JMIR Res Protoc. 2019 Mar 1;8(3):e13161. doi: 10.2196/13161.

3.

CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction.

Ashoori A, Pourhosseini H, Ghodsi S, Salarifar M, Nematipour E, Alidoosti M, Haji-Zeinali AM, Nozari Y, Amirzadegan A, Aghajani H, Jalali A, Hosseini Z, Jenab Y, Geraiely B, Omidi N.

Medicina (Kaunas). 2019 Feb 1;55(2). pii: E35. doi: 10.3390/medicina55020035.

4.

Quercetin Decreases Th17 Production by Down-Regulation of MAPK- TLR4 Signaling Pathway on T Cells in Dental Pulpitis.

Mahmoud Hashemi A, Solahaye Kahnamouii S, Aghajani H, Frozannia K, Pournasrollah A, Sadegh R, Esmaeeli H, Ghadimi Y, Razmpa E.

J Dent (Shiraz). 2018 Dec;19(4):259-264.

5.

Serum levels of subfatin in patients with type 2 diabetes mellitus and its association with vascular adhesion molecules.

Fadaei R, Dadmanesh M, Moradi N, Ahmadi R, Shokoohi Nahrkhalaji A, Aghajani H, Ghorban K.

Arch Physiol Biochem. 2018 Nov 21:1-6. doi: 10.1080/13813455.2018.1538248. [Epub ahead of print]

PMID:
30463448
6.

Toward analyzing and synthesizing previous research in early prediction of cardiac arrest using machine learning based on a multi-layered integrative framework.

Layeghian Javan S, Sepehri MM, Aghajani H.

J Biomed Inform. 2018 Dec;88:70-89. doi: 10.1016/j.jbi.2018.10.008. Epub 2018 Oct 30. Review.

PMID:
30389440
7.

Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals.

Hosseinsabet A, Faal M, Shafiee A, Aghajani H, Sotoudeh Anvari M, Jalali A, Nozari Y, Pourhosseini H, Salarifar M, Amirzadegan A, Kassaian SE, Alidoosti M, Hajizeinali A, Nematipour E.

Arch Iran Med. 2018 Sep 1;21(9):393-398.

8.

Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.

Dadmanesh M, Aghajani H, Fadaei R, Ghorban K.

PLoS One. 2018 Sep 13;13(9):e0204180. doi: 10.1371/journal.pone.0204180. eCollection 2018.

9.

Predictors of Long-term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly.

Aghajani H, Nezami P, Shafiee A, Jalali A, Nezami A, Nozari Y, Pourhosseini H, Kassaian SE, Salarifar M, Hajzeinali A, Amirzadegan A, Alidoosti M, Nematipour E.

Arch Iran Med. 2018 Aug 1;21(8):344-348.

10.

Incidental Finding of a Large Mobile Aortic Arch Mass during Conventional Angiography.

Aghajani H, Yazdani S, Ghafaripoor M, Shajari Z.

J Tehran Heart Cent. 2017 Oct;12(4):171-174.

11.

Predictors of major adverse cardiac events following elective stenting of large coronary arteries.

Aghajani H, Alkamel A, Shafiee A, Jalali A, Nozari Y, Pourhosseini H, Kassaian SE, Salarifar M, Hajizeinali A, Amirzadegan A, Alidoosti M, Masoudkabir F, Nematipour E.

Indian Heart J. 2018 Jan - Feb;70(1):20-23. doi: 10.1016/j.ihj.2017.06.011. Epub 2017 Jun 19.

12.

Measuring Mental Workload with EEG+fNIRS.

Aghajani H, Garbey M, Omurtag A.

Front Hum Neurosci. 2017 Jul 14;11:359. doi: 10.3389/fnhum.2017.00359. eCollection 2017.

13.

Role of serum MMP-9 levels and vitamin D receptor polymorphisms in the susceptibility to coronary artery disease: An association study in Iranian population.

Moradi N, Fadaei R, Ahmadi R, Mohammad MH, Shahmohamadnejad S, Tavakoli-Yaraki M, Aghajani H, Fallah S.

Gene. 2017 Sep 10;628:295-300. doi: 10.1016/j.gene.2017.07.060. Epub 2017 Jul 21.

PMID:
28739397
14.

Decoding human mental states by whole-head EEG+fNIRS during category fluency task performance.

Omurtag A, Aghajani H, Keles HO.

J Neural Eng. 2017 Dec;14(6):066003. doi: 10.1088/1741-2552/aa814b.

PMID:
28730995
15.

Dog Footprint in the Heart.

Aghajani H, Yazdani S, Forouzan Nia SK, Vahidi H, Aghajani F.

J Tehran Heart Cent. 2016 Oct 3;11(4):198-202.

16.

Assessment of mental workload by EEG+FNIRS.

Aghajani H, Omurtag A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3773-3776. doi: 10.1109/EMBC.2016.7591549.

PMID:
28269110
17.

Effect of bucladesine, pentoxifylline, and H-89 as cyclic adenosine monophosphate analog, phosphodiesterase, and protein kinase A inhibitor on acute pain.

Salehi F, Hosseini-Zare MS, Aghajani H, Seyedi SY, Hosseini-Zare MS, Sharifzadeh M.

Fundam Clin Pharmacol. 2017 Aug;31(4):411-419. doi: 10.1111/fcp.12282. Epub 2017 Apr 26.

PMID:
28267871
18.

Evaluation of longitudinal left ventricular function in patients with coronary artery ectasia and vitamin D deficiency by 2D speckle tracking echocardiography.

Aghajani H, Faal M, Hosseinsabet A.

Echocardiography. 2017 Mar;34(3):397-406. doi: 10.1111/echo.13467. Epub 2017 Feb 2.

PMID:
28150401
19.

Evaluation of left atrial function via two-dimensional speckle-tracking echocardiography in patients with coronary artery ectasia.

Aghajani H, Faal M, Hosseinsabet A, Mohseni-Badalabadi R.

J Clin Ultrasound. 2017 May;45(4):231-237. doi: 10.1002/jcu.22435. Epub 2017 Jan 21.

PMID:
28109125
20.

Effect of temperature on surface characteristics of nitrogen ion implanted biocompatible titanium.

Aghajani H, Motlagh MS.

J Mater Sci Mater Med. 2017 Feb;28(2):29. doi: 10.1007/s10856-016-5843-x. Epub 2017 Jan 20.

PMID:
28108957
21.

Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.

Fadaei R, Moradi N, Baratchian M, Aghajani H, Malek M, Fazaeli AA, Fallah S.

PLoS One. 2016 Dec 29;11(12):e0168773. doi: 10.1371/journal.pone.0168773. eCollection 2016.

22.

Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors.

Kassaian SE, Fathi Y, Lotfi-Tokaldany M, Salarifar M, Alidoosti M, Haji-Zeinali AM, Aghajani H, Amirzadegan A, Nozari Y, Mortazavi SH, Jalali A, Saroukhani S.

Crit Pathw Cardiol. 2016 Sep;15(3):89-94. doi: 10.1097/HPC.0000000000000079.

PMID:
27465002
23.

Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.

Parsa E, Saroukhani S, Majlessi F, Poorhosseini H, Lofti-Tokaldany M, Jalali A, Salarifar M, Nematipour E, Alidoosti M, Aghajani H, Amirzadegan A, Kassaian SE.

Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr.

24.

A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention.

Kassaian SE, Saroukhani S, Alaeddini F, Salarifar M, Capodanno D, Poorhoseini H, Lotfi-Tokaldany M, Leesar MA, Aghajani H, Hakki-Kazzazi E, Alidoosti M, Haji-Zeinali AM, Saifi M, Nematipour E.

J Tehran Heart Cent. 2015 Oct 27;10(4):167-75.

25.

Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.

Poorhoseini HR, Kassaian SE, Hoseini K, Saroukhani S, Salarifar M, Alidoosti M, Nematipour E, Haji-Zeinali AM, Amirzadegan A, Seyyed Mohammadzadeh MH, Khadem Vatan K, Aghajani H, Sheikh Fathollahi M, Farrokh-Eslamlou H.

Ther Adv Cardiovasc Dis. 2016 Aug;10(4):206-13. doi: 10.1177/1753944716629868. Epub 2016 Feb 7.

26.

Relationship between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention.

Alidoosti M, Salarifar M, Hajizeinali AM, Kassaian SE, Nematipour E, Aghajani H, Lotfi-Tokaldany M, Kazazi EH.

J Tehran Heart Cent. 2015;10(1):18-23. Epub 2015 Jan 8.

27.

Percutaneous Mitral Valve Repair with the Edge-to-Edge Technique: Case Series of First Iranian Experience.

Kassaian SE, Karbassi A, Sahebjam M, Aghajani H, Amin A, Ahmadbeigi N, Abbasi K, Salehiomran A, Poorhosseini H, Salarifar M.

J Tehran Heart Cent. 2014 Jan 12;9(1):46-51.

28.

C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study.

Ghasemi A, Aghajani H, Fallah S, Assadi M, Seifi M.

Anatol J Cardiol. 2015 Jan;15(1):8-12. doi: 10.5152/akd.2014.5135. Epub 2014 Feb 10.

29.

Effect of Early Treatment With Tirofiban on Initial TIMI Grade 3 Flow of Patients With ST Elevation Myocardial Infarction.

Salarifar M, Mousavi M, Yousefpour N, Nematipour E, Kassaian SE, Poorhosseini H, Hajizeinali A, Alidoosti M, Aghajani H, Nozari Y, Amirzadegan A, Bozorgi A, Genab Y.

Iran Red Crescent Med J. 2014 Jan;16(1):e9641. doi: 10.5812/ircmj.9641. Epub 2014 Jan 5.

30.

Designing and standardizing a questionnaire for evaluating knowledge, attitude, and practice of Iranian adults with cardiovascular diseases about oral health.

Rasouli-Ghahroudi AA, Rokn AR, Khorsand A, Aghajani H, Amini A, Shamshiri AR, Rahimi H, Kabir A.

ARYA Atheroscler. 2013 Nov;9(6):350-6.

31.

Opium consumption and mid-term outcome of percutaneous coronary intervention in men.

Sharafi A, Pour Hosseini HR, Jalali A, Salarifar M, Nematipour E, Shojanasab M, Aghajani H, Amirzadegan A, Nozari Y, Alidoosti M, Zeinali AH, Kassaian SE.

J Tehran Heart Cent. 2014;9(3):115-9. Epub 2014 Jul 3.

32.

Diagnosis of early Alzheimer's disease based on EEG source localization and a standardized realistic head model.

Aghajani H, Zahedi E, Jalili M, Keikhosravi A, Vahdat BV.

IEEE J Biomed Health Inform. 2013 Nov;17(6):1039-45. doi: 10.1109/JBHI.2013.2253326.

PMID:
24240722
33.

Mutations of the connexin 37 and 40 gap-junction genes in patients with acute myocardial infarction.

Seifi M, Fallah S, Ghasemi A, Aghajani H, Razaghi M, Danaei N.

Clin Lab. 2013;59(3-4):343-8.

PMID:
23724624
34.

Discrimination of bilateral finger photoplethysmogram responses to reactive hyperemia in diabetic and healthy subjects using a differential vascular model framework.

Keikhosravi A, Aghajani H, Zahedi E.

Physiol Meas. 2013 May;34(5):513-25. doi: 10.1088/0967-3334/34/5/513. Epub 2013 Apr 22.

PMID:
23603938
35.

Medical biotechnology trends and achievements in iran.

Mahboudi F, Hamedifar H, Aghajani H.

Avicenna J Med Biotechnol. 2012 Oct;4(4):200-5.

36.

Impact of side-branch flow in coronary bifurcation intervention.

Poorhosseini HR, Kassaian SE, Hosseini SK, Fotoohi M, Salarifar M, Alidoosti M, Sharafi A, Nozari Y, Nematipour E, Aghajani H, Haji Zeinali AM, Amirzadegan A, Babapour B, Seyed Mohammad Zadeh MH.

J Tehran Heart Cent. 2012 Aug;7(3):100-5. Epub 2012 Aug 31.

37.

Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation.

Poorhosseini HR, Hosseini SK, Davarpasand T, Lotfi Tokaldany M, Salarifar M, Kassaian SE, Alidoosti M, Nozari Y, Nematipour E, Haji Zeinali AM, Aghajani H, Amirzadegan AR.

J Tehran Heart Cent. 2012 Spring;7(2):47-52. Epub 2012 May 31.

38.

On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes.

Poorhosseini H, Kassaian SE, Aghajani H, Alidoosti M, Hajizeinali AM, Salarifar M, Nematipour E, Amirzadegan AR, Sheikhfathollahi M, Shafiee N, Hakki-Kazazi E, Tokaldany ML.

Tex Heart Inst J. 2012;39(1):24-9.

39.

Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity.

Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Zabetian A, Mehrabi Y, Kelishadi R, Aghajani H.

Arch Iran Med. 2010 Sep;13(5):426-8. doi: 010135/AIM.0011. No abstract available.

40.

Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity.

Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Mehrabi Y, Kelishadi R, Hadaegh F.

Arch Iran Med. 2010 May;13(3):243-4. No abstract available.

41.

Relationship of pharmacist interaction with patient knowledge of dispensed drugs and patient satisfaction.

Garjani A, Rahbar M, Ghafourian T, Maleki N, Garjani A, Salimnejad M, Shamsmohammadi M, Baghchevan V, Aghajani H.

East Mediterr Health J. 2009 Jul-Aug;15(4):934-43.

Supplemental Content

Loading ...
Support Center